Report from Incubate Policy Lab and Charles River Associates Finds Congressional Budget Office Underestimates Negative Impact of Drug Pricing Legislation Washington, D.C., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Today, Incubate Policy Lab and Charles River Associates published a report demonstrating that a leading proposal that would allow the federal...

Life Sciences Investors Sound the Alarm Over Drug Price Negotiations at Incubate Panel Washington, D.C., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Yesterday, a group of early-stage life science investors and biotech CEOs joined together with a prominent patient advocate to speak out against...